Cyberonics says mistake prompted FDA warning
This article was originally published in Clinica
Executive Summary
Cyberonics, a US firm which received an FDA warning letter regarding the FDA's reporting regulations, said that a misunderstanding of the reporting requirements led the company to report adverse events once a year, rather than once every 30 days.